Olink Holding AB (publ) (NASDAQ:OLK) Upgraded to Hold at Zacks Investment Research

Zacks Investment Research upgraded shares of Olink Holding AB (publ) (NASDAQ:OLK) from a sell rating to a hold rating in a research report report published on Wednesday morning, Zacks.com reports.

According to Zacks, “Olink Holding AB provides a platform of products and services which are deployed across major biopharmaceutical companies and clinical and academic institutions to deepen the understanding of real-time human biology. It operates principally in Europe, North America and Asia. Olink Holding AB is headquartered in Uppsala, Sweden. “

Separately, SVB Leerink cut their price target on shares of Olink Holding AB (publ) from $50.00 to $40.00 and set an outperform rating for the company in a report on Thursday, November 11th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, Olink Holding AB (publ) has an average rating of Hold and an average target price of $39.60.

OLK opened at $12.57 on Wednesday. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.39 and a quick ratio of 7.32. The company’s 50 day simple moving average is $20.23 and its two-hundred day simple moving average is $27.15. Olink Holding AB has a 1-year low of $10.64 and a 1-year high of $42.20.

Olink Holding AB (publ) (NASDAQ:OLK) last released its earnings results on Tuesday, November 9th. The company reported ($0.05) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.04) by ($0.01). Olink Holding AB (publ) had a negative return on equity of 5.24% and a negative net margin of 30.42%. The business had revenue of $19.97 million during the quarter, compared to analysts’ expectations of $20.28 million. Equities research analysts anticipate that Olink Holding AB will post -0.22 EPS for the current year.

Hedge funds and other institutional investors have recently made changes to their positions in the company. FMR LLC increased its holdings in Olink Holding AB (publ) by 13.0% in the 2nd quarter. FMR LLC now owns 4,165,423 shares of the company’s stock valued at $143,375,000 after purchasing an additional 478,834 shares during the last quarter. Price T Rowe Associates Inc. MD increased its holdings in Olink Holding AB (publ) by 3.8% in the 2nd quarter. Price T Rowe Associates Inc. MD now owns 3,961,568 shares of the company’s stock valued at $136,357,000 after purchasing an additional 144,456 shares during the last quarter. RTW Investments LP increased its holdings in Olink Holding AB (publ) by 5.6% in the 3rd quarter. RTW Investments LP now owns 1,318,188 shares of the company’s stock valued at $31,966,000 after purchasing an additional 70,000 shares during the last quarter. Capital International Investors increased its holdings in Olink Holding AB (publ) by 17.7% in the 2nd quarter. Capital International Investors now owns 1,177,156 shares of the company’s stock valued at $40,518,000 after purchasing an additional 177,156 shares during the last quarter. Finally, BlackRock Inc. increased its holdings in Olink Holding AB (publ) by 247.1% in the 2nd quarter. BlackRock Inc. now owns 1,056,316 shares of the company’s stock valued at $36,359,000 after purchasing an additional 751,988 shares during the last quarter. Institutional investors and hedge funds own 26.20% of the company’s stock.

Olink Holding AB (publ) Company Profile

Olink Holding AB (publ) provides various products and services for academic, government, biopharmaceutical, biotechnology, and other institutions focused on life science research. Its products include Olink Explore for cardiovascular and metabolic diseases, oncology, neurology, or inflammation; Olink Target product line; and Olink Focus product line consists of custom developed solutions for customers that have identified a small number of proteins of interest to focus on.

Recommended Story: How does a dividend reinvestment plan work?

Get a free copy of the Zacks research report on Olink Holding AB (publ) (OLK)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Olink Holding AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olink Holding AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.